Experimental study of carriers of bone morphogenetic protein used for spinal fusion

Journal of Orthopaedic Science

Volumn 9, Issue 2, 2004, Pages 142-151

  Minamide, Akihito ^a   Kawakami, Mamoru ^a   Hashizume, Hiroshi ^a   Sakata, Ryosuke ^a   Yoshida, Munehito ^a   Tamaki, Tetsuya ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Animal model; Biomaterials; Bone morphogenetic protein; Spinal fusion

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; CALCIUM PHOSPHATE; CARRIER PROTEIN; COLLAGEN TYPE 1; EOSIN; HEMATOXYLIN; HYDROXYAPATITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRODESIS; ARTICLE; BIOMECHANICS; COMPARATIVE STUDY; CONTROLLED STUDY; NONHUMAN; POROSITY; RABBIT; RADIODIAGNOSIS; SPINE FUSION; STAINING; STRENGTH; TENSILE STRENGTH;

EID: 1942488354     PISSN: 09492658     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00776-003-0749-0     Document Type: Article

References (26)

1. Boden SD, Schimandle JH, Hutton WC. An experimental lumbar intertransverse process spinal fusion model: radiographic, histologic, and biomechanical healing characteristics. Spine 1995;20:412-20.
2. Boden SD, Titus L, Hair G, et al. Volvo Award in Basic Sciences: lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1). Spine 1998;23:2486-92.
3. Boden SD, Martin GJ, Morone MA, et al. The use of coralline hydroxyapatite with bone marrow, autogenous bone graft, or osteoinductive bone protein extract for posterolateral lumbar spine fusion. Spine 1999;24:320-7.
4. Boden SD, Martin GJ, Morone MA, et al. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate. Spine 1999;24:1179-85.
5. David SM, Gruber HE, Meyer RA, et al. Lumbar spinal fusion using recombinant human bone morphogenetic protein in the canine: a comparison of three dosages and two carriers. Spine 1999;24:1973-9.
6. Hashizume H, Tamaki T, Oura H, et al. Changes in the extracellular matrix on the surface of sintered bovine bone implanted in the femur of a rabbit: an immunohistochemical study. J Orthop Sci 1998;3:42-53.
7. Katoh T, Sato K, Kawamura M, et al. Osteogenesis in sintered bone combined with bovine bone morphogenetic protein. Clin Orthop 1993;287:266-75.
8. Kurashina K, Kurita H, Hirano M, et al. Calcium phosphate cement: in vitro and in vivo studies of the α-tricalcium phosphatedicalcium phosphate dibasic-tetracalcium phosphate monoxide system. J Mater Sci Mater Med 1995;6:340-7.
9. Lieberman JR, Daluiski A, Stevenson S, et al. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am 1999;81:905-17.
10. Lou J, Xu F, Merkel K, et al. Gene therapy: adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. J Orthop Res 1999;17:43-50.
11. Matsumoto T, Kawakami M, Kuribayashi K, et al. Effects of sintered bovine bone on cell proliferation, collagen synthesis, and osteoblastic expression in MC3T3-E1 osteoblast-like cells. J Orthop Res 1999;17:586-92.
12. Meyer RA, Gruber HE, Howard BA, et al. Safety of recombinant human bone morphogenetic protein-2 after spinal laminectomy in the dog. Spine 1999;24:747-54.
13. Minamide A, Kawakami M, Hashizume H, et al. Evaluation of carriers of bone morphogenetic protein for spinal fusion. Spine 2001;26:933-9.
14. Miyamoto S, Takaoka K, Okada T, et al. Polylactic acid-polyethylene glycol block copolymer: a new biodegradable synthetic carrier for bone morphogenetic protein. Clin Orthop 1993;294:333-43.
15. Morone MA, Boden SD, Hair G, et al. The Marshall R. Urist Young Investigator Award: gene expression during autograft lumbar spine fusion and the effect of bone morphogenetic protein 2. Clin Orthop 1998;351:252-65.
16. Saito N, Okada T, Toba S, et al. New synthetic absorbable polymers as BMP carriers: plastic properties of poly-D,L-lactic acid-polyethylene glycol block copolymers. J Biomed Mater Res 1999;47:104-10.
17. Sandhu HS, Kanim LE, Kabo JM, et al. Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine 1996;21:2115-22.
18. Schimandle JH, Boden SD, Hutton WC. Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 1995;20:1326-37.
19. Takaoka K, Nakahara H, Yoshikawa H, et al. Ectopic bone induction on and in porous hydroxyapatite combined with collagen and bone morphogenetic protein. Clin Orthop 1988;234:250-4.
20. Tamaki T, Sakurai K, Kasamatsu N. Results of basic and clinical studies of true bone ceramics. In: Urist MR, O'Connor BT, Burwell RG, editors. Bone grafts: derivatives and substitutes. Oxford: Butterworth-Heinemann; 1994. p. 235-44.
21. Tay BK-B, Le AX, Heilman M, et al. Use of a collagen-hydroxyapatite matrix in spinal fusion: a rabbit model. Spine 1998;23:2276-81.
22. Ueno Y, Shima Y, Ueyoshi A, et al. Experimental studies of sintered bone implantation. Bessatsu Seikeigeka 1985;8:85-8 (in Japanese).
23. Urist MR, DeLange RJ, Finerman GA. Bone cell differentiation and growth factors. Science 1983;220:680-6.
24. Yamamoto H, Niwa S, Hori M, et al. Mechanical strength of calcium phosphate cement in vivo and in vitro. Biomaterials 1998;19:1587-91.
25. Yasko AW, Lane JM, Fellinfer EJ, et al. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). J Bone Joint Surg Am 1992;74:659-70.
26. Yubao L, Xingdong Z, de Groot K. Hydrolysis and phase transition of alpha-tricalcium phosphate. Biomaterials 1997;18:737-41.